Dr Reddys Laboratories share price added a percent in the morning session on June 28 after the company launched 2-deoxy-D-glucose (2-DG), a therapeutic application for treatment of COVID-19 patients.
The stock was trading at Rs 5,352.10, up Rs 40.75, or…
Dr Reddy#39;s Labs share price gains over launch of COVID-19 treatment drug
Share this article
More News

(XFLX) Market Performance Analysis
November 22, 2026

GSN’s Kirkley says tech retreat could spill into crypto
November 22, 2026

(VSC) Investment Strategy and Analysis
November 22, 2026

Hundreds Of Billions Of SHIB Move Across Crypto Exchanges
November 22, 2026

(UCSH.U) Market Performance Analysis
November 22, 2026

Bitcoin price rebounds from $55K after historic sell-off, is $72K next?
November 22, 2026

(MSFH) Advanced Equity Analysis
November 22, 2026